Simultaneous measurement of allantoin and urate in plasma: analytical evaluation and potential clinical application in oxidant:antioxidant balance studies.

pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996:1311–40. 7. Henderson PA, Hillman RS. Characteristics of iron dextran utilization in man. Blood 1969;34:357–75. 8. American Regent Laboratories. Dexferrum, iron dextran injection, USP. Package insert. Shirley, NY: American Regent Laboratories, 1996. 9. Nissenson AR, Lindsay RM, Swan S, Seligman PA, Strobos J. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American trial. Am J Kidney Dis 1999;33:471–82. 10. Persijn JP, Van Der Slik W, Riethorst A. Determination of serum iron and latent iron-binding capacity (LIBC). Clin Chim Acta 1971;35:91–8. 11. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Tietz NW, ed. Textbook of clinical chemistry. Philadelphia, PA: WB Saunders, 1986:1578– 82. 12. Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H. Clinical use of the total dose intravenous infusion of iron dextran. J Lab Clin Med 1988;111:566–70.